BioLineRx Ltd Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
3 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow Monday, October 1, 2018 8:21 PM EDT
Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.
In this article: AFMD, BLRX, SNDX Also: BMY, FPRX
Read
Week In Review: Xynomic Signs $502 Million Deal For Boehringer's RAF Inhibitor
Article By: ChinaBio® Today Saturday, November 4, 2017 4:58 PM EDT
Xynomic Pharma, a US-Shanghai clinical-stage oncology drug developer, acquired exclusive global rights to a 2nd-generation RAF inhibitor from Boehringer Ingelheim. Xynomic, hoping BI 882370 is a best-in-class drug, agreed to a $502 million package.
In this article: BLRX, ILMN, TEVA, NAVB Also: INTC, BABA
Read
E Trump's Kvittle
Article By: Vivian Lewis Tuesday, May 23, 2017 12:24 AM EDT
The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.
In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW
Read
Week In Review: Week's Deals Create New China Life Science Alliances
Article By: ChinaBio® Today Saturday, August 27, 2016 5:14 PM EDT
Almost a half billion dollars in deals were worked out in the China biotech space last week, the largest being Luye Medical Group's commitment of $300 million to bring up-to-date healthcare to a large healthcare complex.
In this article: BLRX, DHRM
Read
Monday Morning Pre-Market Insights: AMD, ZIOP, EPZM, BLRX
Article By: TipRanks Monday, June 22, 2015 8:45 AM EDT
Monday Morning Pre-Market Insights: Advanced Micro Devices, Inc., ZIOPHARM Oncology, Inc., Epizyme, Inc. and BioLineRx, Ltd.
In this article: AMD, BLRX, EPZM, ZIOP
Read
Analysts Positive On BioLineRx Ltd. Following Ph2 Testing Expansion For AML
Article By: TipRanks Tuesday, May 5, 2015 7:55 AM EDT
On May 4, BioLineRx announced the expansion stage of the Phase 2 clinical trial for BL-8040, a drug for acute myeloid leukemia, or AML. Top-line results will be announced in the fourth quarter of this year.
In this article: BLRX
Read
Roth Capital Weighs In On 5 Biotech Stocks To Watch
Article By: TipRanks Sunday, April 5, 2015 1:27 PM EDT
As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.” Though the analyst rates 15 biotech stocks, we have highlighted 5 of them.
In this article: CLDX, BLRX, CRIS, GNVC
Read
3 Pharmaceutical Stocks Set For Massive Earnings Growth In 2015
Article By: Zacks Investment Research Monday, March 2, 2015 3:04 PM EDT
if you are looking for potential top picks in the space, consider some of the buy ranked stocks we have highlighted here. Not only have all three seen rising earnings estimates as of late, but they all have strong growth prospects for 2015 as well.
In this article: SCMP, LCI, BLRX, IHE
Read
1 to 8 of 8 Posts